-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Tarsus Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q2 2024.
- Tarsus Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$33.3M, a 1.47% decline year-over-year.
- Tarsus Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$156M, a 63.3% decline year-over-year.
- Tarsus Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$143M, a 128% decline from 2022.
- Tarsus Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$62.7M, a 416% decline from 2021.
- Tarsus Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$12.2M, a 55% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)